MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2021

    Impulse Control Disorders Following Bilateral Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The INTREPID Randomized Controlled Trial

    T. Stiep, A. Ramirez-Zamora, A. Tröster, R. Jain, L. Chen, M. Okun (Gainesville, USA)

    Objective: To assess frequency and outcomes of impulsivity in study participants receiving bilateral subthalamic deep brain stimulation (STN-DBS) for treatment of Parkinson’s Disease (PD) who…
  • MDS Virtual Congress 2021

    Baseline cognitive profile is closely associated with long-term motor prognosis in newly diagnosed Parkinson’s disease

    SJ. Chung, YJ. Kim, YH. Sohn, PH. Lee (Yongin-Si, Republic of Korea)

    Objective: To investigate the association between cognitive function at baseline and the progression of motor disability in Parkinson’s disease (PD). Background: There is increasing clinical…
  • MDS Virtual Congress 2021

    The retrograde procedural memory in people with Parkinson’s disease with or without freezing of gait – a cross-sectional study.

    L. Pauly, A. Rauschenberger, C. Pauly, M. Hansen, L. Pavelka, A. Hanff, V. Schröder, A. Leist, R. Krüger (Esch-Sur-Alzette, Luxembourg)

    Objective: To investigate the retrograde procedural memory in people with typical Parkinson’s disease (PwP) with or without freezing of gait (FOG). We hypothesized that the…
  • MDS Virtual Congress 2021

    Cortical microstructural alterations are more sensitive than morphology changes to cortical degeneration in Parkinson’s disease with mild cognitive impairment

    X. Bai, T. Guo, X. Guan, C. Zhou, J. Wu, M. Zhang (Hangzhou, China)

    Objective: To compare the sensitivity of detection cortical degenerative changes in patients with Parkinson’s disease (PD) and mild cognitive impairment (MCI) between the diffusion magnetic…
  • MDS Virtual Congress 2021

    Does cognition, depression and quality of life influence the balance of elderly with Parkinson’s disease ?.

    L. Pereira, P. Broto, M. Terra, N. Barboza, H. Oliveira Araújo, M. Bueno, S. Smaili (Londrina, Brazil)

    Objective: To verify whether there is a correlation between cognition, depression and quality of life with balance in the elderly with Parkinson's disease. Background: Regarding…
  • MDS Virtual Congress 2021

    Findings from a Community-based LOUD Crowd® Program for People with Parkinson Disease

    S. Parveen, A. Mandaville (Stillwater, USA)

    Objective: SPEAK OUT!® and LOUD Crowd® programs target the communicative functioning of people with Parkinson disease (PD). The current study includes findings from a year-long…
  • MDS Virtual Congress 2021

    Cognitive impairment in patients with Alzheimer’s disease and Parkinson’s disease

    O. Chyniak (Sumy, Ukraine)

    Objective: To compare the results of a neuropsychological study in patients with Alzheimer's disease and Parkinson's disease. Background: Recently, Parkinson's disease (PD) is increasingly considered…
  • MDS Virtual Congress 2021

    Comparisons Between Parkinson’s Disease Patients and At-Risk Individuals: Can Olfactory Deficits and Cognitive Measures Serve as Preclinical Markers?

    L. Pimer, J. Fisk, M. Khan, R. Mckelvey, H. Robertson, T. Rolheiser, K. Schoffer, K. Good (Halifax, Canada)

    Objective: To examine whether individuals at increased risk of developing Parkinson’s disease (PD) show specific cognitive impairments suggestive of progression towards PD. Background: Olfactory deficits…
  • MDS Virtual Congress 2021

    Association between Hippocampal Subfields, CSF Biomarkers, and Cognition in non-demented Parkinson’s patients

    S. Becker, O. Granert, M. Timmers, A. Pilotto, L. van Nueten, B. Roeben, G. Salvadore, W. Galpern, J. Streffer, K. Scheffler, W. Maetzler, D. Berg, I. Liepelt-Scarfone (Calgary, Canada)

    Objective: To determine whether hippocampal subfield volumes in non-demented Parkinson’s Disease (PD) are primarily predicted by cognition or CSF β-amyloid 1–42 (Aβ42) levels. Background: The…
  • MDS Virtual Congress 2021

    Effectiveness of a novel cognitive rehabilitation program based on mindfulness and reminiscence in patients with Parkinson’s Disease and Mild Cognitive Impairment: a pilot study

    M. Reitano, M. Dini, F. Ruggiero, S. Tagini, F. Solca, B. Poletti, A. Priori, R. Ferrucci (Milan, Italy)

    Objective: To evaluate the efficacy of a new integrated rehabilitation program based on Mindfulness and Cognitive Training (MILC-tr) on cognitive functions and mood in patients…
  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley